Fourthly, similar to prostate cancer, it has been shown that expression of AR splice variant such as AR-V7 lacking all or a portion of ligand binding domain results in constitutively active AR and regulates a transcriptional program distinct from that of full-length AR (52). This evidence concerns the gene AR and prostate carcinoma.